Avacta Group PLC (LSE:AVCT) - Share price - Overview

Stock Report

Avacta Group PLC AVCT

Last Price
GBX66.50

Day Change
0.00|0.00%

As of 22/01/2018
15:58:36 GMT | GBX
Minimum 15 Minutes Delay.

Last Close66.50p
Day Range65.10 - 67.30
Mkt Cap45.87Mil
52-Wk Range60.00 - 98.00
Yield %0.00
ISINGB00BYYW9G87
Volume5,025
P/E-7.16
P/S16.63
P/CF-10.72

Share Price

Total Returns 22/01/2018

 Chg (%)  
More ...
Avacta Group PLC2.31 
FTSE 100 TR GBP1.74
 
Financials
201520162017
More ...
Income Statement
Turnover1.812.172.74
Operating Profit-5.57-5.66-7.98
Net Profit-4.89-4.65-6.37
Reported EPS-20.10-6.86-9.31
Balance Sheet
Current Assets9.5022.3415.80
Non Current Assets11.9115.2215.75
Total Assets21.4037.5531.55
Current Liabilities1.801.671.66
Total Liabilities2.271.701.66
Total Equity19.1335.8629.89
Cash Flow
Operating Cash Flow-0.34-4.90-6.07
Net Change in Cash-4.152.19-0.36
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2018-9.22-10.95--6.07---
2019-9.72-11.44--5.81---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/01/2018PurchaseDr. Michael Albin64.605,8053,750.00
16/10/2017PurchaseDr. Michael Albin70.605,3113,750.00
21/08/2017PurchaseProf Alastair Smith74.5033,22524,753.00
12/07/2017PurchaseDr. Michael Albin86.304,3453,750.00

Company Profile

Avacta Group PLC is a United Kingdom based company, which caters to the healthcare sector. It develops medical diagnostic products such as reagents and arrays which are helpful in drug discovery.

Sector

Medical Devices

Market Position

1151 of 1835 Companies

Index

FTSE AIM All Share

Outlook

(04/12/2017) "...look to the future with confidence of further technical and commercial progress"

Next Event 03/04/2018

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-5.9514.145.53
Div Yld (E)0.004.064.03
PEG (E)0.00-0.460.98
ROCE-44.81179.53180.33
Op Mrgn-291.41-8.37-126.27
EPS Grwth0.005.7922.39
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Trevor Nicholls
Chief ExecutiveProf Alastair Smith
Chief Financial Officer & Company SecretTony Gardiner
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.